DAPK1 and non-small cell lung carcinoma: Those results were separately a little greater than other findings that p16 is methylated in ~25-41% of NSCLC, DAPK in 16-44% and RARβ in 40-43% [25,26], which the differences may mainly result from ethnic variants.